Form4insider filings, from the source

SEC Form 4 · accession 0001654954-18-001721

CorMedix Inc. · CRMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Period of report
Feb 16, 2018
Accepted (ET)
Feb 20, 2018 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $0.001 par value per shareF1holding———195,379D
Common Stock, $0.001 par value per shareF2holding———115,757IWade Capital Corporation Money Purchase Plan
Common Stock, $0.001 par value per shareholding———10,000IReporting Person's Wife

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy Common Stock)F3$0.57Feb 16, 2018A40,000A—Feb 16, 2028Common Stock40,00040,000D
Restricted Stock UnitsF4—Feb 16, 2018A10,000A——Common Stick10,00010,000D
Restricted Stock UnitsF4—Feb 16, 2018A6,000A——Common Stock6,0006,000D
Stock Option (Right to Buy Common Stock)F5$0.45holding————Jun 25, 2027Common Stock75,00075,000D
Warrant (Right to Purchase Common Stock)$0.90holding———Jan 8, 2015Jan 8, 2020Common Stock22,50022,500D
Warrant (Right to Purchase Common Stock)F2$0.90holding———Jan 8, 2015Jan 8, 2020Common Stock15,00015,000I

Explanation of responses